Dividends Calendar Earnings Calendar
SNDX

SNDX | Syndax Pharmaceuticals Inc

Healthcare sector
Syndax Pharmaceuticals Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Waltham, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 1.07B
  • Prev closed:
  • Open: 17.84
  • High: 18.46
  • Low: 17.18
  • 52 week low: 13.02
  • 52 week high: 27.12
  • Dividends:No Dividends

Next ER: May 8, 2023 



Top Stories (SNDX)

    Company Profile

    Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Through our pipeline agents, entinostat, a late stage, class 1 specific HDAC inhibitor and SNDX-6352, a phase 1 anti-CSF-1R monoclonal antibody, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax corporate headquarters are in Waltham, MA.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 7, 2023
    May 8, 2023-0.59 / -0.65- / 800K
    February 28, 2023-0.62 / -0.65- / 1.6M
    November 7, 2022- / -0.665- / 1.5M
    August 8, 2022-0.62 / -0.6367- / 1.38M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 2, 2023 19.79 20.84
    20.87
    19.65
    		 843K -5.94%
    May 1, 2023 21.04 20.59
    21.23
    20.59
    		 916K 2.38%
    Apr 28, 2023 20.55 20.38
    20.77
    20.21
    		 561K 0.83%
    Apr 27, 2023 20.38 20.97
    21.5
    20.36
    		 537K -2.07%
    Apr 26, 2023 20.81 21.08
    21.37
    20.69
    		 488K -1.42%
    Apr 25, 2023 21.11 21.13
    21.43
    20.91
    		 430K -0.8%
    Apr 24, 2023 21.28 21.5
    21.58
    21.04
    		 400K -1.02%
    Apr 21, 2023 21.5 21.58
    21.67
    21.26
    		 504K -0.14%
    Apr 20, 2023 21.53 20.65
    22
    20.65
    		 1.0M 3.51%
    Apr 19, 2023 20.8 20.29
    20.97
    20.11
    		 436K 1.96%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2005
    • Employees:43

    News

    News for (SNDX)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  W. Morrison
    • CFO :  Daphne Karydas
    • Treasurer :  Daphne Karydas
    • Chief Medical Officer :  Michael L. Meyers

    Talk about Syndax Pharmaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 8, 2023 (Same day)

    pypl six tsn swks dk wdc dvn su dish brk.b enr mck 


    Jump to (Finance sites)

    Google   
             

    Research 


    Investor page

    ir.syndax.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 75
    HOLD 25
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet